Quantum BioPharma Ltd.
QNTM · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $495 | $549 | $1,648 | $4,280 |
| G&A Expenses | $4,018 | $4,223 | $1,608 | $1,694 |
| SG&A Expenses | $4,018 | $4,223 | $1,608 | $1,694 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $235 | $81 | $141 | $267 |
| Operating Expenses | $4,748 | $4,853 | $3,397 | $6,241 |
| Operating Income | -$4,748 | -$4,853 | -$3,397 | -$6,241 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $0 | -$4,913 | -$5,342 | $785 |
| Pre-Tax Income | -$4,748 | -$9,766 | -$8,740 | -$5,456 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$5,319 | -$9,253 | -$8,577 | -$5,360 |
| % Margin | – | – | – | – |
| EPS | -1.25 | -3.23 | -7.52 | -5.22 |
| % Growth | 61.3% | 57% | -44.1% | – |
| EPS Diluted | -1.25 | -3.23 | -7.52 | -5.22 |
| Weighted Avg Shares Out | 3,801 | 3,021 | 1,137 | 1,027 |
| Weighted Avg Shares Out Dil | 3,801 | 3,021 | 1,137 | 1,027 |
| Supplemental Information | – | – | – | – |
| Interest Income | $100 | $91 | $67 | $132 |
| Interest Expense | $105 | $236 | $351 | $16 |
| Depreciation & Amortization | $145 | $141 | $130 | $113 |
| EBITDA | -$4,497 | -$9,389 | -$8,260 | -$5,327 |
| % Margin | – | – | – | – |